Results 41 to 50 of about 53,574 (237)

Case report of aplastic anaemia detected in third trimester of pregnancy: dilemmas faced [PDF]

open access: yes, 2020
Aplastic anaemia with pregnancy is rarely encountered. Management of aplastic anaemia in pregnancy primarily involves a multidisciplinary approach offering supportive care.
Udgire, Sunil Prabhakar   +2 more
core   +1 more source

HLA-lacking clones in aplastic anaemia: Adaptive or maladaptive? [PDF]

open access: yes
HLA loss represents the result of immune forces shaping bone marrow clonal dynamics in immune aplastic anaemia. Human leukocyte antigen (HLA)-deficient clones may rescue haematopoiesis by evading immune attacks, potentially guiding treatment strategies ...
Lima A. C. M., Pagliuca S., Gurnari C.
core   +1 more source

Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group

open access: yes, 2001
Granulocyte-colony stimulating factor (G-CSF) is being increasingly used in healthy volunteers to harvest haemopoietic stem cells. A possible role of G-CSF in the development of clonal disorders or leukaemia has been suggested.
Bacigalupo, A   +20 more
core   +2 more sources

Active Emergency Management of Adult Acute Epiglottitis: An Analysis of 570 Cases

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective Acute epiglottitis, which is primarily caused by bacterial infection, can quickly progress to life‐threatening airway obstruction. The first 24 h after symptom onset is a critical window for management. However, few studies have evaluated the effect of emergency management during this period or have identified the factors that ...
Bo‐Jun Shen   +7 more
wiley   +1 more source

Indigenous antithymocyte globulin-equine to treat aplastic anaemia in adults: a case series from two centres in northeast India

open access: yesHematology, Transfusion and Cell Therapy
Background: Immunosuppressive therapy is the standard management of adults with aplastic anaemia. Antithymocyte globulin is used as first-line treatment of patients not eligible for bone marrow transplantation.
Asif Iqbal   +2 more
doaj   +1 more source

Allopurinol: Sorrow to the marrow

open access: yesJournal of Family Medicine and Primary Care, 2020
Allopurinol is a xanthine oxidase inhibitor used in management of chronic gout. It acts by reducing the amount of uric acid by inhibiting purine metabolism.
U R Raaju, Siddharth Gosavi, K Sriharsha
doaj   +1 more source

Nomenclature on Immune‐Mediated Drug Reactions: An EAACI Position Paper

open access: yesAllergy, EarlyView.
ABSTRACT Over the past several decades, there have been significant advances in our understanding of both immunological and pharmacological mechanisms of adverse drug reactions (ADRs). Immune‐mediated drug reactions (IMDRs) represent a small proportion of ADRs and are caused by a pathological activation of the immune system or inflammatory pathways ...
Maria J. Torres   +19 more
wiley   +1 more source

Epidemiological features of aplastic anaemia in Pakistan [PDF]

open access: yes, 2001
Objective: To complete the data on the demographic features of patients diagnosed to have aplastic anemia at a single institution over a 7.5 years period. Methods: Demographic information was retrieved from the patients medical records retrospectively as
Adil, Salman   +3 more
core  

Regulatory T-cells in Acquired Aplastic Anaemia

open access: yes, 2020
: Introduction: Acquired aplastic anaemia is characterized by destruction of haematopoietic stem cells by cytotoxic T lymphocytes. Regulatory T-cells have been reported to be suppressed in aplastic anaemia like many other autoimmune disorders ...
Maqsood, Sidra   +5 more
core  

Low dose cyclosporine-a therapy in severe aplastic anaemia

open access: yes, 2001
Objective : The present study was conducted to evaluate the efficacy of low dose cyclosporine-A in the patients of severe aplastic anaemia, who cannot afford allogenic bone marrow transplantation and immunosuppressive therapy with antithymocyte globulin ...
Jha, V. C.   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy